000			02083 a2200577 4500
005			20250516113353.0
264		0	_c20130418
008			201304s 0 0 eng d
022			_a1179-1926
024	7		_a10.1007/s40262-012-0010-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aMoreau, Philippe
245	0	0	_aPharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma. _h[electronic resource]
260			_bClinical pharmacokinetics _cDec 2012
300			_a823-9 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Intravenous
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aHumans
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xblood
650	0	4	_aProteasome Endopeptidase Complex _xblood
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aRecurrence
700	1		_aKaramanesht, Ievgenii I
700	1		_aDomnikova, Natalia
700	1		_aKyselyova, Maryna Y
700	1		_aVilchevska, Kateryna V
700	1		_aDoronin, Vadim A
700	1		_aSchmidt, Alexander
700	1		_aHulin, Cyrille
700	1		_aLeleu, Xavier
700	1		_aEsseltine, Dixie-Lee
700	1		_aVenkatakrishnan, Karthik
700	1		_aSkee, Donna
700	1		_aFeng, Huaibao
700	1		_aGirgis, Suzette
700	1		_aCakana, Andrew
700	1		_avan de Velde, Helgi
700	1		_aDeraedt, William
700	1		_aFacon, Thierry
773	0		_tClinical pharmacokinetics _gvol. 51 _gno. 12 _gp. 823-9
856	4	0	_uhttps://doi.org/10.1007/s40262-012-0010-0 _zAvailable from publisher's website
999			_c22141480 _d22141480